Investor · 1 deal
Every published round Carl Stubbings took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Diag-Nose.io | Seed | 30 Jan 2025 | $3.2m | Participant | Startup Daily, SmartCompany |
Companies Carl Stubbings has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Diag-Nose.io | Melbourne based company improving clinical management and drug discovery for chronic resp… | 30 Jan 2025, Seed | 1 | 0 |
Fund closes reported for Carl Stubbings, as distinct from the investments it has made.
Companies Carl Stubbings has backed that another company then bought. An exit for the holding, not a deal Carl Stubbings did.
Stories naming Carl Stubbings. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne biotech Diag-Nose.io raised a seed round led by Breakthrough Victoria for its AI respiratory diagnostic, backed by physicians, funds and executives; one investor joins its board.